Yahoo Web Search

Search results

    • Amgen investors await weight-loss drug data

      Amgen investors await weight-loss drug data

      Reuters via AOL· 3 hours ago

      Amgen has said it expects to have first-in-human results from a small, early-stage trial of experimental oral compound AMG786 before the end of June. "We...